ro 31-8220 has been researched along with Lung Neoplasms in 3 studies
Ro 31-8220: a protein kinase C inhibitor
Lung Neoplasms: Tumors or cancer of the LUNG.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hemström, TH | 1 |
Sandström, M | 1 |
Zhivotovsky, B | 1 |
Aggarwal, S | 1 |
Kim, SW | 1 |
Ryu, SH | 1 |
Chung, WC | 1 |
Koo, JS | 1 |
Courage, C | 1 |
Bradder, SM | 1 |
Jones, T | 1 |
Schultze-Mosgau, MH | 1 |
Gescher, A | 1 |
3 other studies available for ro 31-8220 and Lung Neoplasms
Article | Year |
---|---|
Inhibitors of the PI3-kinase/Akt pathway induce mitotic catastrophe in non-small cell lung cancer cells.
Topics: Androstadienes; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell S | 2006 |
Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Growth Processes; Cell Line, Tumor; C | 2008 |
Characterisation of novel human lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine.
Topics: Adenocarcinoma; Alkaloids; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cass | 1997 |